HCPCS Level II · Drugs administered other than oral method
J1203Injection, cipaglucosidase alfa-atga, 5 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J1203
J1203 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, cipaglucosidase alfa-atga, 5 mg.
It was added to HCPCS effective 04/01/2024.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj, cipaglucosidase, 5 mg
- Date added
- 04/01/2024
- Action effective
- 04/01/2024
- BETOS
- O1E
Related J12xx codes
- J1200Injection, diphenhydramine hcl, up to 50 mg
- J1201Injection, cetirizine hydrochloride, 0.5 mg
- J1202Miglustat, oral, 65 mg
- J1205Injection, chlorothiazide sodium, per 500 mg
- J1212Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
- J1230Injection, methadone hcl, up to 10 mg
- J1240Injection, dimenhydrinate, up to 50 mg
- J1245Injection, dipyridamole, per 10 mg
- J1250Injection, dobutamine hydrochloride, per 250 mg
- J1260Injection, dolasetron mesylate, 10 mg
- J1265Injection, dopamine hcl, 40 mg
- J1270Injection, doxercalciferol, 1 mcg
Common questions about J1203
Is HCPCS J1203 still valid?
- Yes. J1203 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J1203?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.